Patent 9531665

PTAB challenges

AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.

Active provider: Google · gemini-2.5-pro

Proceedings on file (0)

All PTAB activity →

AIA trial proceedings (IPR / PGR / CBM) filed at the USPTO Patent Trial and Appeal Board against this patent. Sourced from the USPTO Open Data Portal and refreshed every six hours; each proceeding number deep-links to the PTAB E2E docket.

No PTAB proceedings on file. This patent has not been challenged via IPR, PGR, or CBM. The absence is itself a signal — well-asserted patents eventually attract IPRs. The LLM analysis below may surface filings the ODP feed hasn’t indexed yet.

PTAB challenges

AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.

✓ Generated

Proceedings Overview

As of May 12, 2026, there have been zero AIA trial proceedings (IPR, PGR, or CBM) filed against US patent 9,531,665. The patent's claims remain entirely untested before the Patent Trial and Appeal Board (PTAB), which presents a clean slate for a defendant considering a validity challenge.

Strategic Summary

The absence of any PTAB challenges against US patent 9,531,665 is a significant strategic data point. Despite a documented history of assertion in district court since late 2024, no accused infringer has yet sought to invalidate the patent's claims at the USPTO.

  • Claim Status: All claims of the '665 patent, including independent claims 1 and 7, are UNTESTED at the PTAB. No claims have been canceled or sustained through an AIA trial.
  • Estoppel Landscape: For a company currently facing an assertion from Contactwave LLC, the estoppel landscape is completely open. No prior art or invalidity arguments are precluded under 35 U.S.C. § 315(e)(2) because no prior IPRs have been filed. A defendant would be the first to bring a challenge and would have the full universe of prior art patents and printed publications at its disposal.
  • Pattern Signals: The patent has been asserted by a patent assertion entity, Contactwave LLC, which has a pattern of filing suits that resolve relatively quickly through voluntary dismissals with prejudice. This litigation pattern, combined with the lack of PTAB filings, could suggest that the defendants have so far found it more economically viable to settle early rather than engage in a costly validity fight in either district court or at the PTAB. There is no indication that a defensive aggregator like Unified Patents has been involved.

Recommended Next Steps

For a defendant facing a demand letter or complaint citing US patent 9,531,665, the immediate takeaway is that a PTAB challenge is a fully available defensive option.

  • No PTAB Activity: It must be stated plainly: no inter partes review (IPR) or other AIA proceeding has been filed against this patent. The patent's validity has not been vetted by the PTAB's expert administrative patent judges, a process often seen as more efficient and specialized for invalidity analysis than district court litigation.
  • Opportunity for Defendant: A defendant would be the first to challenge the patent at the PTAB. This presents an opportunity to neutralize the threat by invalidating the asserted claims without the higher costs and complexities of a full district court litigation cycle. A thorough prior art search would be the logical first step to assess the feasibility of filing a strong IPR petition against claims 1 and 7 and any asserted dependent claims.

Generated 5/12/2026, 11:29:41 PM